These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 10200564

  • 1. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.
    Hedlund TE, Meech SJ, Srikanth S, Kraft AS, Miller GJ, Schaack JB, Duke RC.
    Cell Death Differ; 1999 Feb; 6(2):175-82. PubMed ID: 10200564
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adenovirus expressing p27KIP1 induces apoptosis against cholangiocarcinoma cells by triggering Fas ligand on the cell surface.
    Yamamoto K, Katayose Y, Suzuki M, Unno M, Sasaki T, Mizuma M, Shiraso S, Ohtuka H, Cowan KH, Seth P, Matsuno S.
    Hepatogastroenterology; 2003 Feb; 50(54):1847-53. PubMed ID: 14696417
    [Abstract] [Full Text] [Related]

  • 4. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N.
    Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065
    [Abstract] [Full Text] [Related]

  • 5. Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.
    Hyer ML, Sudarshan S, Schwartz DA, Hannun Y, Dong JY, Norris JS.
    Cancer Gene Ther; 2003 Apr 01; 10(4):330-9. PubMed ID: 12679806
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. FasL gene therapy: a new therapeutic modality for head and neck cancer.
    ElOjeimy S, McKillop JC, El-Zawahry AM, Holman DH, Liu X, Schwartz DA, Day TA, Dong JY, Norris JS.
    Cancer Gene Ther; 2006 Aug 01; 13(8):739-45. PubMed ID: 16543918
    [Abstract] [Full Text] [Related]

  • 9. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells.
    Fujino M, Li XK, Suda T, Hashimoto M, Okabe K, Yaginuma H, Mikoshiba K, Guo L, Okuyama T, Enosawa S, Amemiya H, Amano T, Suzuki S.
    Xenotransplantation; 2001 May 01; 8(2):115-24. PubMed ID: 11328582
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas.
    Shinoura N, Yoshida Y, Asai A, Kirino T, Hamada H.
    Cancer Gene Ther; 2000 May 01; 7(5):732-8. PubMed ID: 10830720
    [Abstract] [Full Text] [Related]

  • 11. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S, Vega M, Garban H, Bonavida B.
    Clin Immunol; 2006 Sep 01; 120(3):297-309. PubMed ID: 16784892
    [Abstract] [Full Text] [Related]

  • 12. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L, Mosberger I, Grusch M, Rudas M, Chott A.
    J Pathol; 2000 Jan 01; 190(1):20-30. PubMed ID: 10640988
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY.
    Cancer Gene Ther; 2003 Nov 01; 10(11):814-22. PubMed ID: 14605667
    [Abstract] [Full Text] [Related]

  • 16. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B, Litvak A, Sharma S, Mhashilkar AM, Chada S, Ramesh R.
    Cancer Res; 2005 Apr 15; 65(8):3017-24. PubMed ID: 15833826
    [Abstract] [Full Text] [Related]

  • 17. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
    Rubinchik S, Wang D, Yu H, Fan F, Luo M, Norris JS, Dong JY.
    Mol Ther; 2001 Nov 15; 4(5):416-26. PubMed ID: 11708878
    [Abstract] [Full Text] [Related]

  • 18. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
    Zhang J, Xu G.
    Cancer Genet Cytogenet; 2007 Dec 15; 179(2):112-7. PubMed ID: 18036397
    [Abstract] [Full Text] [Related]

  • 19. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 15; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 20. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.
    J Immunol; 1999 Jun 15; 162(12):7350-7. PubMed ID: 10358186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.